XXII 22nd Century Group Inc.

Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)

Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed.

To read this report, please visit XXII's landing page on the Emerging Growth website, located here: .

XXII's new management has successfully reduced operating cash losses in the first nine months of 2024 and further decreased the Company's debt load in early 2025. The Company expects to reach EBITDA breakeven by Q4 2025, driven by stabilized CMO sales, a revamped VLN® (first-to-market 95%-reduced nicotine cigarette) strategy, and disciplined expense management. The previous concerns about bankruptcy that arose in late 2023 have been alleviated, and the Company no longer anticipates share issuance for survival purposes.

However, XXII's shares remain materially beaten down, primarily due to concerns about past restructuring efforts, share dilution, and the bankruptcy risk that loomed in late 2023. Despite these challenges, the Company's outlook is now significantly more positive, with the focus shifting toward growth and profitability.

22nd Century Group, Inc. provides contract manufacturing (CMO) services for conventional combustible tobacco products to third-party branded companies. The Company also engages in the sale and distribution of its own proprietary VLN® very-low-nicotine tobacco products. 22nd Century Group is pioneering nicotine harm reduction in the tobacco industry, enabling smokers to take control of their nicotine consumption. The Company was founded in 1998 and is headquartered in Mocksville, North Carolina.

For more information, please refer to the full initiation report .

**Contact:**

Emerging Growth Research

###

This press release includes forward-looking statements that are subject to risks and uncertainties. Please refer to the full report for additional disclosures.

To view the source version of this press release, please visit

EN
19/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 22nd Century Group Inc.

 PRESS RELEASE

Emerging Growth Research Releases New Initiation Report on the 22nd Ce...

Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed. To read this report, please visit XXII's landing page on the Emerging Growth website, located here: .XXII's new management has successfully reduced operating cash losses in the first nine months of 2024 and further decreased the Company'...

 PRESS RELEASE

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transact...

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously announced warrant inducement offering. During the inducement period, certain holders of the Company’s existing warrants acqui...

 PRESS RELEASE

22nd Century Appoints Larry Firestone as Chairman and CEO

22nd Century Appoints Larry Firestone as Chairman and CEO Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco Assets BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of Lawrence (Larry) Firestone as the Company's Chairman and Chief Executive Officer. Nora Sullivan, former Chair of the Board, commented, “Larry is a seasoned executive known for his 'hands-on...

 PRESS RELEASE

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchi...

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requirements BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada corporation ...

 PRESS RELEASE

22nd Century Group Continues VLN® Expansion, Now Retailing in More Tha...

22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores Adds another 500+ stores BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has again expanded its VLN® retail presence with more than 500 additional locations across 11 states. With these latest additions, 22nd Century Group’s FDA-authorized VLN® reduced nicotine content cigarett...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch